Table 4. Mean and 95% confidence interval for each CITT outcome measure, by treatment group and time.

Outcome /	HBPP		HBCVAT+		OBVAT		OBPT
Time	Mean	95% CI	Mean	95% CI	Mean	95% CI	Mean	95% CI
CI Symptom Survey score
At Baseline	27.8	25.8, 29.8	31.7	29.3, 34.1	30.2	27.7, 32.7	29.8	27.4, 32.2
At Week 12
Unadjusted	21.3	18.0, 24.6	24.7	21.9, 27.5	15.1	12.6, 17.6	21.9	18.8, 25.0
Adjusteda	22.9	20.4, 25.5	23.5	20.9, 26.0	15.0	12.6, 17.4	21.9	19.3, 24.4
Total Changea	-7.1	-9.6, -4.5	-6.0	-8.6, -3.4	-14.8	-17.2, -12.4	-7.8	-10.4, -5.3
Near point of convergence break (cm)
At Baseline	14.7	12.5, 16.9	14.4	12.4, 16.4	13.3	11.6, 15.0	14.4	12.3, 16.5
At Week 12
Unadjusted	8.0	6.1, 9.9	6.8	5.2, 8.4	3.5	3.0, 4.0	10.3	8.4, 12.2
Adjusteda	7.8	6.4, 9.2	6.8	5.4, 8.2	4.0	2.7, 5.3	10.3	8.9, 11.6
Total Changea	-6.4	-7.8, -5.0	-7.5	-8.9, -6.1	-10.4	-11.7, -9.0	-3.9	-5.3, -2.5
Positive fusional vergence blur or break (Δ)b
At Baseline	11.3	10.2, 12.4	10.5	9.4, 11.6	11.0	9.9, 12.1	11.0	10.2, 11.8
At Week 12
Unadjusted	19.1	16.8, 21.4	22.8	19.8, 25.8	30.7	27.5, 33.9	17.8	15.5, 20.1
Adjusteda	18.9	16.2, 21.6	23.0	20.3, 25.7	30.5	28.0, 33.1	17.8	15.2, 20.5
Total Changea	7.9	5.2, 10.6	12.0	9.3, 14.8	19.7	17.1, 22.3	6.9	4.2, 9.5

HBPP: Home-based pencil push-up therapy

HBCVAT+: Home-based computer vergence/accommodative therapy and pencil push-ups

OBVAT: Office-based vergence/accommodative therapy with home reinforcement

OBPT: Office-based placebo therapy with home reinforcement

CI: Confidence Interval

Total Change: Week 12 minus baseline

^aAdjusted for measurement obtained at the baseline examination

^bThe blur finding was used, but if the patient did not report a blur, the break finding was used